Becton, Dickinson and news
The WiseView Research desk's stories that name Becton, Dickinson and, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The BDX page →
- HeadlineBD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options
- HeadlineFirst Eagle U.S. Value Fund Q3 2026 Portfolio Review
- HeadlineBDX Stock Gains 25.5% in Six Months: What's Behind the Rally?
- HeadlineBD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients
- CongressRo Khanna bought $1,001 - $15,000 of BDX
- HeadlineWill Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?
- HeadlineBD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2026
- HeadlineBDX Expands U.S. Manufacturing With $19B Healthcare Investment
- HeadlineBD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results
- HeadlineBD Appoints Ferass Abuzaina as Worldwide President of Surgery
- HeadlineBD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America's Healthcare Resilience
- HeadlineBD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- CongressThomas Kean sold $1,001 - $15,000 of BDX
- CongressKevin Hern sold $15,001 - $50,000 of BDX
- CongressRo Khanna bought $1,001 - $15,000 of BDX
- CongressLisa McClain bought $1,001 - $15,000 of BDX
- CongressLisa McClain sold $1,001 - $15,000 of BDX
- CongressThomas H. Kean bought $1,001 - $15,000 of BDX
- CongressRob Bresnahan bought $1,001 - $15,000 of BDX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.